Advertisement

Topics

FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint

08:46 EST 14 Feb 2018 | FDA

FDA approves Erleada (apalutamide), first treatment for non-metastatic, castration-resistant prostate cancer

Original Article: FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint

NEXT ARTICLE

More From BioPortfolio on "FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint"

Advertisement
Quick Search
Advertisement
Advertisement